Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 1863 entries
View as:

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04377659 Org: User:
Start: 05/01/20 End: 10/28/22 Due: 10/28/23

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00043095 Org: User:
Start: 06/30/02 End: - Due: -

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Phase: N/A Priority: Normal
NCT ID: NCT00887809 Org: User:
Start: 04/30/09 End: 11/30/14 Due: 11/30/15

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04337970 Org: User:
Start: 04/06/20 End: 05/23/25 Due: 05/23/26

Adaptive Radiotherapy for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03096808 Org: User:
Start: 03/15/17 End: 10/22/21 Due: 10/22/22

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03635892 Org: User:
Start: 08/13/18 End: 08/31/25 Due: 08/31/26

A Study of LN-144 in People With Metastatic Melanoma to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT05640193 Org: User:
Start: 11/25/22 End: 11/30/25 Due: 11/30/26

Breath Training Exercise for the Reduction of Chronic Dyspnea

Phase: N/A Priority: Normal
NCT ID: NCT01831388 Org: User:
Start: 03/31/13 End: 07/31/18 Due: 07/31/19

Cytogenetic and Molecular Genetic Studies in Bone Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00579930 Org: User:
Start: 12/31/93 End: 02/29/16 Due: 02/28/17

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02178345 Org: User:
Start: 06/24/14 End: 12/03/21 Due: 12/03/22

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01011894 Org: User:
Start: 11/06/09 End: 02/23/16 Due: 02/23/17

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03122509 Org: User:
Start: 04/24/17 End: 04/28/21 Due: 04/28/22

Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00006040 Org: User:
Start: 04/30/00 End: 11/30/03 Due: 11/30/04

A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02833233 Org: User:
Start: 06/30/16 End: 06/07/24 Due: 06/07/25

Study Assessing the Potential for Reduced Rates of Implant Failure Using Multi-Beam Intensity-Modulated Radiation Therapy for Locally Advanced Breast Cancer Patients with Implant Reconstructions

Phase: N/A Priority: Normal
NCT ID: NCT02086578 Org: User:
Start: 03/11/14 End: 09/13/24 Due: 09/13/25

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03681483 Org: User:
Start: 10/31/18 End: 07/08/24 Due: 07/08/25

Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02628912 Org: User:
Start: 12/31/15 End: 01/31/18 Due: 01/31/19

Use of Screening Colonoscopy Among Minority Women and Men

Phase: N/A Priority: Normal
NCT ID: NCT00613873 Org: User:
Start: 07/31/03 End: 01/31/09 Due: 01/31/10

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005618 Org: User:
Start: 02/29/00 End: 03/31/04 Due: 03/31/05

Massage Therapy in Treating Patients With Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00082290 Org: User:
Start: 05/31/03 End: - Due: -

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Phase: N/A Priority: Normal
NCT ID: NCT01642186 Org: User:
Start: 07/12/12 End: 07/16/21 Due: 07/16/22

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02060253 Org: User:
Start: 04/30/14 End: 06/30/18 Due: 06/30/19

A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections

Phase: N/A Priority: Normal
NCT ID: NCT01749332 Org: User:
Start: 12/31/12 End: 12/31/19 Due: 12/31/20

Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major

Phase: N/A Priority: Normal
NCT ID: NCT00658385 Org: User:
Start: 04/30/08 End: 02/28/11 Due: 02/28/12

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02921022 Org: User:
Start: 10/31/16 End: 10/31/25 Due: 10/31/26